عبدالله . ن. . Efficacity of Gefitinib or Erlotinib for EGFR- mutant advanced non-small cell lung carcinoma. Tishreen University Journal -Medical Sciences Series, [S. l.], v. 43, n. 6, p. 25–32, 2022. Disponível em: https://journal.tishreen.edu.sy/index.php/hlthscnc/article/view/11534. Acesso em: 24 nov. 2024.